ACM
Apex Capital Management’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q1 | $21.4M | Buy |
281,742
+45,622
| +19% | +$3.46M | 0.47% | 72 |
|
|
2015
Q4 | $19M | Buy |
236,120
+18,222
| +8% | +$1.46M | 0.42% | 75 |
|
|
2015
Q3 | $13.8M | Sell |
217,898
-48,969
| -18% | -$3.11M | 0.31% | 82 |
|
|
2015
Q2 | $18.8M | Buy |
266,867
+54,027
| +25% | +$3.8M | 0.4% | 75 |
|
|
2015
Q1 | $16.9M | Buy |
212,840
+31,547
| +17% | +$2.5M | 0.4% | 72 |
|
|
2014
Q4 | $11.5M | Buy |
181,293
+45,373
| +33% | +$2.89M | 0.31% | 77 |
|
|
2014
Q3 | $8.12M | Buy |
135,920
+13,264
| +11% | +$792K | 0.24% | 82 |
|
|
2014
Q2 | $6.57M | Buy |
122,656
+16,866
| +16% | +$903K | 0.2% | 93 |
|
|
2014
Q1 | $6.38M | Buy |
105,790
+14,329
| +16% | +$865K | 0.23% | 89 |
|
|
2013
Q4 | $4.85M | Sell |
91,461
-442
| -0.5% | -$23.4K | 0.18% | 97 |
|
|
2013
Q3 | $4.25M | Buy |
91,903
+14,627
| +19% | +$677K | 0.19% | 96 |
|
|
2013
Q2 | $3.17M | Buy |
+77,276
| New | +$3.17M | 0.15% | 116 |
|